This message was sent to ##Email##
Advertisement
|
|
|
|
| |
The ITNS office is closed on Monday, Sept. 2 in observation of the Labor Day holiday.
 
The Transplant Nursing Symposium in Orlando, FL, USA will be here before you know it! Please consider nominating a colleague for an ITNS award.
Transplant Nursing Excellence Award: Recognizes an exemplary nurse (RN or equivalent) for their care of transplant patients and their embodiment of the ITNS mission and values.
Friend of Transplant Nursing Award: Recognizes an individual outside the nursing profession who has supported the efforts of ITNS and made an impact in the field of transplant nursing.
All nominations must be received by Aug. 30, 2019.
  
Interested in printing copies of the patient educational booklets to distribute at your hospital or facility? Visit the online store to purchase unrestricted permission to photocopy or print a patient education handbook for educational use.
 |
|
Promoted by
Veloxis Pharmaceuticals
Follow the journeys of kidney transplant patients who transitioned to a different immunosuppression regimen. After talking with their doctors about their experiences with other options, they decided to make a switch.
Watch video
|
|
Massive Science
Patients in need of life-saving organ transplants can spend years waiting for a suitable donor. The ultimate solution to the organ shortage crisis may be the development of processes to grow healthy transplant-able organs in the lab – and for some, this means growing human organs inside animal hosts.
Chimeras, creatures containing parts from multiple animals, are not a new concept in biology. However, the creation of hybrid chimeras with cells from two different species tends to give us pause, especially when the hybrid is part human. Such experiments blur the boundaries between human and animal that we use to justify animal experimentation in the first place, raising difficult ethical and philosophical questions.
READ MORE
CNN
There are currently 93,000 people in the United States on a waiting list for a donated kidney, yet at least 3,500 donated kidneys are discarded every year, according to a study published in the journal JAMA Internal Medicine.
READ MORE
Becker's Hospital Review
Over 5,800 Americans died waiting for an organ transplant in 2018.
Statistics like this were among the findings of a recent analysis from Health Testing Centers, which examined thousands of data points from the Organ Procurement and Transplantation Network to better understand organ donations. The 5,800 Americans who died waiting for a transplant represent just some of the 113,000 candidates who were on the waitlist last year.
Health Testing Centers released its findings in a series of graphs and lists, including a ranking that outlines the percentage of organ transplant candidates in each state who have waited over five years for an organ.
READ MORE
Advertisement
Veloxis Pharmaceuticals
Explore this phase 3 randomized, double-blind, double-dummy, multicenter, multinational, non-inferiority trial published in the American Journal of Transplantation. The study examined treatment failures defined as BPAR, graft failure, death, and delayed graft function at 3 months and 12 months.
Explore data
|
Cardiovascular Business
A single dose of the lipid-lowerer simvastatin, delivered to an organ donor pre-heart transplant, could decrease postoperative troponin levels in transplant recipients and protect the donor heart against perioperative myocardial ischemic damage.
That’s according to a study authored by Antti I. Nykanen, MD, PhD, and colleagues and published this summer in Circulation.
READ MORE
JHLT
African Americans have lower survival rates after heart transplantation than Caucasians. The aim of this analysis was to evaluate racial differences in gene expression and their associations with survival and the composite outcome of death, retransplant, rejection with hemodynamic compromise, and graft dysfunction in the Outcomes AlloMap Registry.
READ MORE
Medscape
The number of women undergoing solid organ transplants, including kidney, liver, lung, and heart, continues to increase, meaning that we will be seeing more and more patients who are transplant recipients.
The great majority of lower genital tract cancers are caused by persistent high-risk human papillomavirus. The use of immunosuppressive medications, which reduces HPV clearance, places transplant recipients at elevated risk.
READ MORE
Cardiology Advisor
Cardiovascular events are the second most common cause of nonhepatic death after liver transplantation, with an estimated prevalence of 11 percent of liver transplant recipients. Additionally, recipients with metabolic syndrome are up to four times more likely to suffer a CV event than recipients without metabolic syndrome. Furthermore, the rate of CV events after liver transplantation is projected to rise due to the growing prevalence of nonalcoholic fatty liver disease and the increasing age of patients who receive liver transplants.
READ MORE
Transplantation
Frail kidney transplant recipients have higher risk of adverse post-KT outcomes. Yet there is interest in measuring frailty at KT evaluation and then using this information for post-KT risk stratification. Given long wait times for KT, frailty may improve or worsen between evaluation and KT. Patterns, predictors, and post-KT adverse outcomes associated with these changes are unclear.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
